According to the IRLSSG guidelines, when are dopamine-receptor agonists indicated for initial treatment of restless legs syndrome (RLS)?

Updated: Feb 22, 2017
  • Author: Ali M Bozorg, MD; Chief Editor: Selim R Benbadis, MD  more...
  • Print

The use of a dopamine-receptor agonist should be considered for initial treatment of patients with any of the following:

  • Very severe symptoms

  • Excessive weight

  • Comorbid depression

  • Increased risk of falls

  • Cognitive impairment

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!